Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor ® in Ischemic Heart Failure

[
Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor ® in Ischemic Heart Failure
[og_img]
https://www.investing.com/news/press-releases/mesoblast-files-request-for-type-b-meeting-with-fda-to-discuss-accelerated-approval-pathway-for-revascor–in-ischemic-heart-failure-93CH-3964036


Investing.com